Banding without resection (endoscopic mucosal ligation) as a novel approach for the ablation of short-segment Barrett's epithelium: Results of a pilot study

Edgardo Diaz-Cervantes, Antonio De-La-Torre-Bravo, Stuart Jon Spechler, Ernesto Torres-Durazo, Sergio Sobrino-Cossio, Olimpia Martínez-Carrillo, Javier Gamboa-Robles

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

OBJECTIVES: During an endoscopic variceal ligation, we banded a varix with an overlying tongue of Barrett's epithelium (BE). One month later, the tongue was no longer visible, suggesting that banding could be used to eradicate BE. AIM: To assess the safety and efficacy of banding without resection (BWR) using a variceal banding device for eradicating BE. METHODS: From April 2004 through September 2005, 30 patients with BE were treated with BWR plus omeprazole 20 mg t.i.d. BWR was repeated monthly until two consecutive endoscopic and histological examinations showed no BE. Thirty Barrett's patients treated with omeprazole 20 mg t.i.d. alone served as a control group. RESULTS: The BWR treatment group comprised 29 patients with short-segment BE (SSBE) and one with long-segment disease, whereas all 30 of the control patients had SSBE. During a median follow-up of 16.9 months (range 10-24 months), complete eradication of BE was achieved in 29 of 30 patients (97%) in the BWR group. In contrast, BE persisted in all 30 control patients during the same period (P < 0.0005). The mean total number of bands applied per patient was 6.1 (range 1-14) and the mean number of sessions for complete eradication was 3.1 (range 1-7). Adverse events included only mild chest pain and dysphagia that resolved within days. CONCLUSIONS: BWR appears to be a safe, effective, simple, and widely available technique for eradicating SSBE. This is a pilot study and we do not recommend the ablation of nondysplastic BE at this time. Further studies are needed.

Original languageEnglish (US)
Pages (from-to)1640-1645
Number of pages6
JournalAmerican Journal of Gastroenterology
Volume102
Issue number8
DOIs
StatePublished - Aug 2007

Fingerprint

Barrett Esophagus
Ligation
Omeprazole
Tongue
Endoscopic Mucosal Resection
Varicose Veins
Deglutition Disorders
Chest Pain
Safety
Equipment and Supplies
Control Groups

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Banding without resection (endoscopic mucosal ligation) as a novel approach for the ablation of short-segment Barrett's epithelium : Results of a pilot study. / Diaz-Cervantes, Edgardo; De-La-Torre-Bravo, Antonio; Spechler, Stuart Jon; Torres-Durazo, Ernesto; Sobrino-Cossio, Sergio; Martínez-Carrillo, Olimpia; Gamboa-Robles, Javier.

In: American Journal of Gastroenterology, Vol. 102, No. 8, 08.2007, p. 1640-1645.

Research output: Contribution to journalArticle

Diaz-Cervantes, Edgardo ; De-La-Torre-Bravo, Antonio ; Spechler, Stuart Jon ; Torres-Durazo, Ernesto ; Sobrino-Cossio, Sergio ; Martínez-Carrillo, Olimpia ; Gamboa-Robles, Javier. / Banding without resection (endoscopic mucosal ligation) as a novel approach for the ablation of short-segment Barrett's epithelium : Results of a pilot study. In: American Journal of Gastroenterology. 2007 ; Vol. 102, No. 8. pp. 1640-1645.
@article{690281637195443d8abcf198f3cb766d,
title = "Banding without resection (endoscopic mucosal ligation) as a novel approach for the ablation of short-segment Barrett's epithelium: Results of a pilot study",
abstract = "OBJECTIVES: During an endoscopic variceal ligation, we banded a varix with an overlying tongue of Barrett's epithelium (BE). One month later, the tongue was no longer visible, suggesting that banding could be used to eradicate BE. AIM: To assess the safety and efficacy of banding without resection (BWR) using a variceal banding device for eradicating BE. METHODS: From April 2004 through September 2005, 30 patients with BE were treated with BWR plus omeprazole 20 mg t.i.d. BWR was repeated monthly until two consecutive endoscopic and histological examinations showed no BE. Thirty Barrett's patients treated with omeprazole 20 mg t.i.d. alone served as a control group. RESULTS: The BWR treatment group comprised 29 patients with short-segment BE (SSBE) and one with long-segment disease, whereas all 30 of the control patients had SSBE. During a median follow-up of 16.9 months (range 10-24 months), complete eradication of BE was achieved in 29 of 30 patients (97{\%}) in the BWR group. In contrast, BE persisted in all 30 control patients during the same period (P < 0.0005). The mean total number of bands applied per patient was 6.1 (range 1-14) and the mean number of sessions for complete eradication was 3.1 (range 1-7). Adverse events included only mild chest pain and dysphagia that resolved within days. CONCLUSIONS: BWR appears to be a safe, effective, simple, and widely available technique for eradicating SSBE. This is a pilot study and we do not recommend the ablation of nondysplastic BE at this time. Further studies are needed.",
author = "Edgardo Diaz-Cervantes and Antonio De-La-Torre-Bravo and Spechler, {Stuart Jon} and Ernesto Torres-Durazo and Sergio Sobrino-Cossio and Olimpia Mart{\'i}nez-Carrillo and Javier Gamboa-Robles",
year = "2007",
month = "8",
doi = "10.1111/j.1572-0241.2007.01256.x",
language = "English (US)",
volume = "102",
pages = "1640--1645",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Banding without resection (endoscopic mucosal ligation) as a novel approach for the ablation of short-segment Barrett's epithelium

T2 - Results of a pilot study

AU - Diaz-Cervantes, Edgardo

AU - De-La-Torre-Bravo, Antonio

AU - Spechler, Stuart Jon

AU - Torres-Durazo, Ernesto

AU - Sobrino-Cossio, Sergio

AU - Martínez-Carrillo, Olimpia

AU - Gamboa-Robles, Javier

PY - 2007/8

Y1 - 2007/8

N2 - OBJECTIVES: During an endoscopic variceal ligation, we banded a varix with an overlying tongue of Barrett's epithelium (BE). One month later, the tongue was no longer visible, suggesting that banding could be used to eradicate BE. AIM: To assess the safety and efficacy of banding without resection (BWR) using a variceal banding device for eradicating BE. METHODS: From April 2004 through September 2005, 30 patients with BE were treated with BWR plus omeprazole 20 mg t.i.d. BWR was repeated monthly until two consecutive endoscopic and histological examinations showed no BE. Thirty Barrett's patients treated with omeprazole 20 mg t.i.d. alone served as a control group. RESULTS: The BWR treatment group comprised 29 patients with short-segment BE (SSBE) and one with long-segment disease, whereas all 30 of the control patients had SSBE. During a median follow-up of 16.9 months (range 10-24 months), complete eradication of BE was achieved in 29 of 30 patients (97%) in the BWR group. In contrast, BE persisted in all 30 control patients during the same period (P < 0.0005). The mean total number of bands applied per patient was 6.1 (range 1-14) and the mean number of sessions for complete eradication was 3.1 (range 1-7). Adverse events included only mild chest pain and dysphagia that resolved within days. CONCLUSIONS: BWR appears to be a safe, effective, simple, and widely available technique for eradicating SSBE. This is a pilot study and we do not recommend the ablation of nondysplastic BE at this time. Further studies are needed.

AB - OBJECTIVES: During an endoscopic variceal ligation, we banded a varix with an overlying tongue of Barrett's epithelium (BE). One month later, the tongue was no longer visible, suggesting that banding could be used to eradicate BE. AIM: To assess the safety and efficacy of banding without resection (BWR) using a variceal banding device for eradicating BE. METHODS: From April 2004 through September 2005, 30 patients with BE were treated with BWR plus omeprazole 20 mg t.i.d. BWR was repeated monthly until two consecutive endoscopic and histological examinations showed no BE. Thirty Barrett's patients treated with omeprazole 20 mg t.i.d. alone served as a control group. RESULTS: The BWR treatment group comprised 29 patients with short-segment BE (SSBE) and one with long-segment disease, whereas all 30 of the control patients had SSBE. During a median follow-up of 16.9 months (range 10-24 months), complete eradication of BE was achieved in 29 of 30 patients (97%) in the BWR group. In contrast, BE persisted in all 30 control patients during the same period (P < 0.0005). The mean total number of bands applied per patient was 6.1 (range 1-14) and the mean number of sessions for complete eradication was 3.1 (range 1-7). Adverse events included only mild chest pain and dysphagia that resolved within days. CONCLUSIONS: BWR appears to be a safe, effective, simple, and widely available technique for eradicating SSBE. This is a pilot study and we do not recommend the ablation of nondysplastic BE at this time. Further studies are needed.

UR - http://www.scopus.com/inward/record.url?scp=34547643021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547643021&partnerID=8YFLogxK

U2 - 10.1111/j.1572-0241.2007.01256.x

DO - 10.1111/j.1572-0241.2007.01256.x

M3 - Article

C2 - 17488252

AN - SCOPUS:34547643021

VL - 102

SP - 1640

EP - 1645

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 8

ER -